Astria Therapeutics: Pipeline And Market Potential Post BioCryst Acquisition

Astria Therapeutics, Inc. acquired by BioCryst for $13 per share, with the deal set to finalize in 1Q26. Click here to read why ATXS stock is a Buy.
Junior Mining Network

Sun Peak Metals Provides Overview of New Projects in Saudi Arabia as Part of SDC Transaction

VANCOUVER, BC, AL / ACCESS Newswire / October 15, 2025 / Sun Peak Metals Corp. (TSXV:PEAK)(OTCQB:SUNPF) ("Sun Peak" or the ...